GENTING

4.740

+0.02 (+0.4%)

OTHERS GENTING BERHAD ("GENT" OR "THE COMPANY") - GENT'S ASSOCIATE, TAURX PHARMACEUTICALS LTD., ANNOUNCED RESULTS FROM PHASE 3 ALZHEIMER'S DISEASE STUDY, LUCIDITY

GENTING BERHAD

Type Announcement
Subject OTHERS
Description
GENTING BERHAD ("GENT" OR "THE COMPANY") - GENT'S ASSOCIATE, TAURX PHARMACEUTICALS LTD., ANNOUNCED RESULTS FROM PHASE 3 ALZHEIMER'S DISEASE STUDY, LUCIDITY

Further to GENT's announcement dated 1 June 2022, the Company's associate, TauRx Pharmaceuticals Ltd., a leader in tau-based research in Alzheimer’s, had unveiled results from their Phase 3 Alzheimer’s study, LUCIDITY. 

 

Please refer to the attached Press Release for further details.

 

This announcement is dated 6 October 2022.




Please refer attachment below.



Announcement Info

Company Name GENTING BERHAD
Stock Name GENTING
Date Announced 06 Oct 2022
Category General Announcement for PLC
Reference Number GA1-06102022-00111